Claims
- 1. A composition, comprising: a mixture of a prolamine, a plant polar lipid, at least one polyalcohol in a hydro-alcoholic solution, and an active agent, wherein the composition forms a substantially homogeneous dispersion with skin adhesive properties; wherein the dispersion forms a film and wherein the film contains a gradient of concentrations of the active agent.
- 2. A composition according to claim 1, wherein the prolamine is a cereal prolamine.
- 3. A composition according to claim 2, wherein the cereal prolamine is gliadin.
- 4. A composition according to claim 1, wherein the plant polar lipid is isolated from a cereal.
- 5. A composition according to claim 1, wherein the hydro-alcoholic solution is hydro-ethanol.
- 6. A composition according to claim 4, wherein the plant polar lipid is a preparation that includes a ceramide or a glycosylceramide at a concentration greater than 50%.
- 7. A composition according to claim 1, wherein the prolamine has a w/w in the range of 20-40%, the plant polar lipids have a w/w in the range 0.1%-5%.
- 8. A composition according to claim 1, further comprising a plasticizing agent.
- 9. A composition according to claim 8, wherein the polyalcohol comprises a concentration of glycerol or a concentration of sorbitol.
- 10. A composition according to claim 9, wherein the concentration of polyalcohol is in the range of 2.5%-80% dry weight.
- 11. A composition according to claim 1, wherein the active agent is a therapeutic agent.
- 12. A composition according to claim 1, wherein the active agent is a cosmetic agent.
- 13. A composition according to claim 1, wherein the film is rolled into a compact form.
- 14. A composition according to claim 1, wherein the dispersion is in a form suited for adhering at a site selected from oral, buccal, rectal, vaginal and topical sites.
- 15. A composition according to claim 8, wherein the film forms a protective barrier for underlying tissue, on a wound surface.
- 16. A composition according to claim 15, wherein the protective barrier retains a therapeutic agent for promoting wound healing.
- 17. A composition according to claim 1, wherein the dispersion has hemostatic properties.
- 18. A composition according to claim 15, wherein the wound is a burn.
- 19. A composition according to claim 11, wherein the active agent is selected from the group comprising: local and systemic pain relievers, anti-arthritis agents; buccally active agents, agents for enhancing dental hygiene, agents for enhancing mouth hygiene, antimicrobials agents, anesthetic agents, keratolytic agent; wound healing agents; antipyretics; anti-inflammatory agents, antispasmodic agents, sympathomimetic drugs, antiparasitic agents, hypoglycemic drugs, nutritional agents, cardiovascular agents, agents for smoking cessation, vitamins, hemostatic agents, skin growth agents.
- 20. A composition according to claim 12, wherein the active agent is selected from the group comprising: agents for improving skin appearance, topically active agents for treating dermal and nail diseases; anti-hyperpigmentation, anti-blotching, anti-aging, eye contour, slimming, anti-cellulite, soothing/sunburn anti-irritating, skin firming and lifting, anti-elastase and anti-collagenase agents, free radical scavengers, seboregulators, hydratives, and AHA (α-hydroxy acids) specific products.
- 21. A composition according to claim 1, further comprising an oxidizing agent contained within the dispersion.
- 22. A composition according to claim 21, wherein the oxidizing agent is vitamin E.
CROSS REFERENCE
This invention claims priority from provisional application Ser. No. 60/060,897 filed Oct. 3, 1997, the provisional application being here incorporated by reference.
US Referenced Citations (8)
Foreign Referenced Citations (9)
Number |
Date |
Country |
0090559 |
Oct 1983 |
EP |
0187703 |
Jul 1986 |
EP |
0486294 |
May 1992 |
EP |
0518697 |
Dec 1992 |
EP |
0621044 |
Oct 1994 |
EP |
WO9310731 |
Jun 1993 |
WO |
WO9312771 |
Jul 1993 |
WO |
WO9528964 |
Nov 1995 |
WO |
WO9637912 |
Nov 1996 |
WO |
Non-Patent Literature Citations (2)
Entry |
Stella, V., et al. (1995); “Gliadin Films. I: Preparation and in vitro evaluation as a carrier for controlled drug release” International Journal of Pharmaceutics 121 (1995) 117-121. |
Thacharodi, D. and Panduranga Rao, K. (1995); “Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride” Biomaterials 1995, vol. 16 No. 2 145-148. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/060897 |
Oct 1997 |
US |